Sign in

Metastatic breast cancer trials, also abroad

684 open Metastatic breast cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
China224
United States222
France83
Spain73
Italy70
Germany52
South Korea42
Australia36
United Kingdom36
Belgium34
Canada30
Japan23
Poland20
Netherlands19
Taiwan19
Brazil18
Türkiye18
Portugal17
Israel16
Argentina15
Mexico13
Sweden13
Czechia12
Austria11
Hungary11
Ireland11
Denmark10
Puerto Rico9
Switzerland8
Finland8
Singapore8
Bulgaria7
Hong Kong7
India7
Norway7
Romania7
Thailand7
South Africa7
Chile5
Malaysia5
New Zealand5
Slovakia5
Saudi Arabia4
Colombia3
Jordan3
Peru3
United Arab Emirates2
Georgia2
Moldova2
Oman2
Russia2
Slovenia2
Costa Rica1
Algeria1
Egypt1
Guam1
Croatia1
Iceland1
Kenya1
Kazakhstan1
Luxembourg1
Latvia1
Philippines1
Qatar1
Tunisia1
Ukraine1
Uganda1
Venezuela1
Vietnam1

The same trial often runs in several countries

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) has 6 sites in Greece and runs in 40 countries. If a site near you is full, another one may still take people.

See A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) in all 40 countries
Metastatic breast cancer trials in Greece – Frontlight Research